Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXF5XT
|
||||
| Drug Name |
(S)-benzyl 1-(cyanomethylamino)-3-(naphthalen-2-yl)-1-oxopropan-2-ylcarbamate
|
||||
| Synonyms |
CHEMBL200954
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H21N3O3
|
||||
| Canonical SMILES |
O=C(N[C@@H](Cc1ccc2ccccc2c1)C(=O)NCC#N)OCc3ccccc3
|
||||
| InChI |
InChI=1S/C23H21N3O3/c24-12-13-25-22(27)21(26-23(28)29-16-17-6-2-1-3-7-17)15-18-10-11-19-8-4-5-9-20(19)14-18/h1-11,14,21H,13,15-16H2,(H,25,27)(H,26,28)/t21-/m0/s1
|
||||
| InChIKey |
VLRVNSBIFSUWHS-NRFANRHFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.